Imperative Care announced today that its chief operating officer, Daniel Davis, was appointed as the company’s new president.
Davis is slated to oversee the growth of the company’s technology portfolio for the treatment of ischemic and hemorrhagic stroke as president, according to a news release. He will continue in his role as COO and will also join Imperative Care’s board of directors.
“It’s been a real pleasure working with Daniel and benefiting from his steadfast commitment to elevating stroke care which has enabled him to make significant contributions from the outset of his time at Imperative Care,” Imperative Care chairman & CEO Fred Khosravi said in the release. “I am thrilled to see his leadership grow within the organization as he now oversees our efforts to bring much-needed innovation to the field of stroke.”
Campbell, Calif.-based Imperative Care said Davis brings 20 years of experience in sales, marketing and business development to the table, having spent much of his time focused on bringing neurovascular innovations to market. He joined Imperative care in 2019, having previously served as chief commercial officer and president of North America at Penumbra.
“Many of us at Imperative Care are driven by our personal connection to stroke and the pursuit of better, more streamlined care for stroke patients and their families,” Davis said. “Imperative Care’s resolute dedication to innovation across the continuum of stroke care has been inspirational to me. I am convinced that this will position the company to revolutionize the stroke space and excited to continue leading the company alongside Fred and our seasoned leadership team.”